|
RAB35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.205600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.115600E-01 |
| Normal-vs-Stage2 |
6.783400E-01 |
| Normal-vs-Stage3 |
2.884400E-02 |
| Normal-vs-Stage4 |
7.446200E-01 |
| Stage1-vs-Stage2 |
7.767200E-01 |
| Stage1-vs-Stage3 |
1.000100E-02 |
| Stage1-vs-Stage4 |
7.234200E-01 |
| Stage2-vs-Stage3 |
2.886400E-02 |
| Stage2-vs-Stage4 |
6.417800E-01 |
| Stage3-vs-Stage4 |
4.234200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.166000E-01 |
| Normal-vs-AfricanAmerican |
7.675500E-02 |
| Normal-vs-Asian |
8.138600E-01 |
| Caucasian-vs-AfricanAmerican |
1.287560E-01 |
| Caucasian-vs-Asian |
8.713600E-01 |
| AfricanAmerican-vs-Asian |
7.240800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.152400E-01 |
| Normal-vs-Female |
1.859760E-02 |
| Male-vs-Female |
3.671800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.013200E-01 |
| Normal-vs-Extreme_Weight |
6.304600E-01 |
| Normal-vs-Obese |
1.851840E-01 |
| Normal-vs-Extreme_Obese |
9.689600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.105600E-01 |
| Normal_Weight-vs-Obese |
2.535200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.815200E-01 |
| Extreme_Weight-vs-Obese |
9.462100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.685800E-01 |
| Obese-vs-Extreme_Obese |
5.129000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.950400E-04 |
| Normal-vs-Age(41-60Yrs) |
9.171600E-02 |
| Normal-vs-Age(61-80Yrs) |
9.857400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.186600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.176600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.519820E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.239200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.832300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.813900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.582000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.473600E-01 |
| Normal-VS-Type2 PRCC |
8.776200E-01 |
| Normal-VS-KIRP CIMP |
1.811820E-01 |
| Normal-VS-Unclassified PRCC |
2.640100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.451200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.358200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.816200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.769760E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.874360E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.545400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.386400E-01 |
| Normal-vs-N1 |
6.359900E-02 |
| Normal-vs-N2 |
3.009600E-01 |
| N0-vs-N1 |
2.699900E-02 |
| N0-vs-N2 |
5.008600E-01 |
| N1-vs-N2 |
6.824600E-01 |
|
|
